During the past decade, Chung-Hua Hsu conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chung-Hua Hsu" #1 collaborator was "National Yang Ming University" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Chung-Hua Hsu" are "Diabetes Mellitus, Type II" (1 trials), "Hyperlipidemia" (1 trials) and "Type 2 Diabetes" (1 trials). Many other conditions were trialed in "Chung-Hua Hsu" in a lesser frequency.

Most popular intervention types in "Chung-Hua Hsu" are "Dietary Supplement" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Extract of Agaricus blazei Murill" (1 trials), "Green tea extract" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Chung-Hua Hsu" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Chung-Hua Hsu". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Chung-Hua Hsu, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Chung-Hua Hsu, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".